SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Merck
An SI Board Since December 1996
Posts SubjectMarks Bans Symbol
1580 80 0 MRK
Emcee:  Alfred W. Post Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1130 Celebrex was approved today, but label still considers it a NSAID. Details in NHenry Niman-12/31/1998
1129 Tomorrow's Circulation will have a review on the benefits of CP IIb/IIIa inHenry Niman-12/21/1998
1128 CNBC just announced that they would be discussing a new approach to asthma and Henry Niman-12/18/1998
1127 Len, what are you referring to? Your response is vague, ambiguous and childishWilliam Partmann-12/13/1998
1126 Now, Len, that last crack was naughty. Not called for either. His point is weEdwarda-12/13/1998
1125 Crybaby Elmer Flugum-12/13/1998
1124 Len, 1) where is the reference to the study "below"? 2) there are oEdwarda-12/12/1998
1123 No! You posted on SI's Merck board and I will respond to you here. William Partmann-12/12/1998
1122 Please refer all comments to: cocktailtime@yahoo.com Thanks, Len Elmer Flugum-12/12/1998
1121 Len, I seen this same message before. Do you think that Merck is so stupid thWilliam Partmann-12/12/1998
1120 The highly lucrative MERCK product brand name MEVACOR (natural substance named Elmer Flugum-12/12/1998
1119 WAM: Singulair Added To Inhaled Steroids Increases Control Of Asthma Symptoms Anthony Wong-12/12/1998
1118 Merck Study Says Singulair Improves Glaxo Asthma Drug's Effect quote.bloombAnthony Wong-12/11/1998
1117 Today's WSJ has an extensive article on the 55% reduction in breast cancer Henry Niman-12/11/1998
1116 Zocor is stabilizing! This is not good news. Shareholders of Merck expect Rob Loney-12/10/1998
1115 Epicenter and thread, here's Will's report of the analyst meeting at laAnthony Wong-12/10/1998
1114 Ardner, Sorry it wasn't music to your ears. Better hear the truth late thaIbexx-12/10/1998
1113 Anthony: I agree. What doesn't make sense to me is that MRK is a very resEpicenter-12/10/1998
1112 Thread, don't you just love posters who suddenly appear after a stock takesArdner Cheshire, Jr.-12/10/1998
1111 <i>IMHO, I just don't see how MRK can adequately cover the shortfall.David C. Burns-12/10/1998
1110 Thread, Among first-tier pharmas, MRK's pipe line is less robust than mostIbexx-12/10/1998
1109 Epicenter, Merck's "challenges " have been around for some time, Anthony Wong-12/10/1998
1108 I wrote my note before I read all of the upgrades/downgrades (my excuse is thatEpicenter-12/10/1998
1107 Epicenter, there are two ratings cut (Deutsche Bank and Warburg) among the six.Anthony Wong-12/10/1998
1106 I don't understand! How does a downward revised earnings projection and aEpicenter-12/10/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News